Ocular hypotensive lipids

Details for Australian Patent Application No. 2001236665 (hide)

Owner Allergan, Inc.

Inventors Krauss, Achim H. P.; Usansky, Helen H.; Woodward, David F.; Burk, Robert M; Madhu, Cherukury; Chen, June; Andrews, Steven W.

Agent Davies Collison Cave

Pub. Number AU-B-2001236665

PCT Pub. Number WO01/58866

Priority 09500142 08.02.00 US

Filing date 5 February 2001

Wipo publication date 20 August 2001

Acceptance publication date 12 January 2006

International Classifications

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

Event Publications

12 January 2006 Application Accepted

  Published as AU-B-2001236665

11 May 2006 Standard Patent Sealed

28 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001236666

2001236664